The Asia-Pacific medical collagen market is estimated to register a CAGR of 7.00% during the forecast period, 2022-2030, and garner a revenue of $214.10 million by 2030.
ASIA-PACIFIC MEDICAL COLLAGEN MARKET FORECAST 2022-2030
Asia-Pacific Medical Collagen Market by Source (Bovine, Porcine, Other Sources) Market by Product (Gelatine, Hydrolyzed Collagen, Native Collagen, Other Products) Market by Application (Wound Care, Bone Grafts, Tissue Scaffolds, Cartilage Repair, Haemostats, Diagnostics, Vascular Grafts, Other Applications) By Geography
The Asia-Pacific medical collagen market is estimated to register a CAGR of 7.00% during the forecast period, 2022-2030, and garner a revenue of $214.10 million by 2030.
The medical collagen’s diverse applications contribute to its increased demands in the region. It is being included in diets in the form of capsules, eatables, drinks, etc. As a result, the food & beverage industry is incorporating it as an ingredient in their products. Also, collagen is extracted from the skins and bones of pigs and cows since they are the richest protein sources. As there is wide acceptance of meat products in the region, the market analyzed has immense growth opportunities.
To know more about this report, request a free sample copy
The Asia-Pacific medical collagen market growth assessment includes the analysis of Japan, China, Australia & New Zealand, Singapore, Taiwan, Indonesia, South Korea, India, and Rest of Asia-Pacific. China is an emerging collagen market. Several products are being introduced in the beauty and food categories. The two prominent collagen types in the Chinese market are marine collagen in powdered form and collagen peptides. In addition, the key market players are launching new products. For instance, Nestle Health Science opened a flagship store, where it launched collagen products in 2021.
Whereas in South Korea, the increasing acceptance of collagen products has facilitated companies to launch associated beauty and food & beverage products in the market. For instance, Maypharm Co Ltd announced their new product, Mennus, a PLA filler, used for reducing wrinkles, in November 2021. Further, collagen products are famous in Singapore, given their efficiency in maintaining bones and skin health. Also, collagen is available in different forms. These include food, drinks, gummy, and supplements.
The Asia-Pacific medical collagen market segmentation includes source, product, and application. The source segment is further divided into porcine, bovine, and other sources.
Porcine is the most prominent source in the market by type. Porcine-based collagen is obtained from pigs. It is prepared from the skin and bone of the pigs. Consumers are opting for pork-based collagen because it is similar to human collagen that can be easily absorbed by the human body. Therefore, companies are increasingly inclined to porcine.
Further, pigs have I and III collagen as that of the human collagen type used for enhancing the skin. Additionally, porcine has glycine and proline, the amino acids found in pigs. Proline is used by the body to produce collagen and maintain the skin structure, while glycine helps keep the skin smooth and young.
The other collagen sources include avian and marine collagen. The former is also known as collagen type II. In latter, fish is included, containing type I collagen. The collagen from marine sources are rich in protein, which further improves bone, skin, and hair growth.
Some of the leading firms in the Asia-Pacific medical collagen market are Nippi Inc, Nitta Gelatin, Stryker, Symatese, etc.
Nitta Gelatin is a prominent Japanese company that manufactures gelatine and collagen-related products. The company caters to the pharmaceutical, dietary supplement, and food sectors. Its product portfolio includes XactSet™ and CapsiGuard™ DRG gelatin. It is headquartered in Osaka, Japan.
One of its key products, CapsiGuard™ DRG gelatin, is specifically designed to inhibit cross-linkage reactions. It is devoid of additives and chemical modifications, and has a gel strength similar to traditional gelatin.
Report Synopsis:
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Source, Product, Application |
| Countries Analyzed | Japan, China, Australia & New Zealand, Singapore, Taiwan, Indonesia, South Korea, India, and Rest of Asia-Pacific |
| Companies Analyzed |
Collagen Matrix Inc, Connoils Llc, Darling Ingredients Inc, DSM, Gelita, Integra LifeSciences, Italgel, Jellagen, Lapi Gelatine, Nippi Inc, Nitta Gelatin, Stryker, Symatese, Tessenderlo, and Weishardt |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASING AWARENESS
- GROWING DEMAND FROM MEDICAL DEVICES INDUSTRY
- KEY RESTRAINTS
- RESTRICTED DEMANDS DUE TO ANIMAL-BASED PRODUCTS’ USE
- HEALTH-RELATED ISSUES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON MEDICAL COLLAGEN MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- QUALITY
- SIDE-EFFECTS
- PRODUCT EFFECTIVENESS
- PRICE
- MARKET BY SOURCE
- BOVINE
- PORCINE
- OTHER SOURCES
- MARKET BY PRODUCT
- GELATINE
- HYDROLYZED COLLAGEN
- NATIVE COLLAGEN
- OTHER PRODUCTS
- MARKET BY APPLICATION
- WOUND CARE
- BONE GRAFTS
- TISSUE SCAFFOLDS
- CARTILAGE REPAIR
- HAEMOSTATS
- DIAGNOSTICS
- VASCULAR GRAFTS
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- COLLAGEN MATRIX INC
- CONNOILS LLC
- DARLING INGREDIENTS INC
- DSM
- GELITA
- INTEGRA LIFESCIENCES
- ITALGEL
- JELLAGEN
- LAPI GELATINE
- NIPPI INC
- NITTA GELATIN
- STRYKER
- SYMATESE
- TESSENDERLO
- WEISHARDT
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MEDICAL COLLAGEN
TABLE 2: SOME MEDICAL APPLICATIONS OF COLLAGEN
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL COLLAGEN MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY SOURCE, IN 2021
FIGURE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 12: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 17: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HAEMOSTATS, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 26: CHINA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: JAPAN MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: INDIA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: SOUTH KOREA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: INDONESIA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: TAIWAN MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: SINGAPORE MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY SOURCE
- BOVINE
- PORCINE
- OTHER SOURCES
- MARKET BY PRODUCT
- GELATINE
- HYDROLYZED COLLAGEN
- NATIVE COLLAGEN
- OTHER PRODUCTS
- MARKET BY APPLICATION
- WOUND CARE
- BONE GRAFTS
- TISSUE SCAFFOLDS
- CARTILAGE REPAIR
- HAEMOSTATS
- DIAGNOSTICS
- VASCULAR GRAFTS
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.